Measures activity, not value. Not investment advice.
Insiders bought $3M of shares and sold none while an S-1 share registration was filed.
WatchCompanies filing S-1s trailed sector by median 23.8 points in 6 months
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
Frazier Life Sciences Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Industry
Blank checks (Financials)
Listed
Nasdaq, US
No income statement in this company's recent SEC filings in our data (it may report under IFRS, in another currency, or not file with the SEC).
Peers nearest by market cap, its own industry first
Company
Market cap
P/E
P/S
Revenue growth
Net margin
Frazier Life Sciences Acquisition Corp. IIFLSC (this company)
Insider buy/sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
+$3.0M
bought $3.0M, sold $0
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
–
No 13F holdings or share count.
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
–
2,442 shares sold short (30 Oct 2026); no share count in the company's filings in our data
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
1.0
2,442 shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-86%
17K shares sold short in the report before, 2,442 on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
20%
20% of off-exchange volume on 20 Nov 2026 was short sales
News iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
4
4 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
–
4 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.
Price $10.08 on 20 Nov 2026, -2.0% over 12 months (12-month range $10.05 to $10.49)
8-K and other filings
Insider net buying (open market). Insiders bought a net $3.0M in the last 12 months (the 12 months before: $0).
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, capital spending per quarter, institutional holders (13f filers), federal obligations, lobbying spend, workers in warn layoff notices.
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is cash and cash equivalents at period end at $162K (30 Sep 2026), too little history to compare.
Not listed: 4 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0002153598
Ticker
FLSC
Hq location
CA|PALO ALTO|93404 (1 unverified)
Name
Frazier Life Sciences Acquisition Corp. II
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)5 records23 Sep 2026 to 17 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)6 data points6 Aug 2026 to 30 Sep 2026
SEC Form 4 insider transactions1 record, 4 data points15 Oct 2026 to 15 Oct 2026
FINRA short interest (twice monthly)5 data points15 Oct 2026 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)54 data points14 Oct 2026 to 20 Nov 2026